Health Care Policy
-
CAR-T Cell Cancer Drug Coverage
New drugs like CAR-T cell cancer therapies are coming online. CMS reimbursement and regulations surrounding these innovations will be a case study in how our health care system responds.
-
Bipartisan Support to Address Primary Care, Telehealth, Drug Costs
Multiple hearings in the U.S. Senate are starting to reveal areas for potential agreement. Here’s our look at what that legislation may include.
-
Will Congress Address “Surprise Bills” in Health Care?
The issue of “surprise bills” in health care continues to gain traction with the media, patient advocates and others, but will this issue rise to the level of Congressional action? Read on to find out.
-
Senate Hearing: 3 Key Takeaways on Health Care Cost, Innovation
A U.S. Senate committee held another hearing on health care costs and innovations. What three takeaways are there for the future? Read on!
-
Medicare Opens Up Virtual Health, Telehealth Reimbursement
Telehealth and virtual health continue to gain steam, and Congress and HHS are opening the doors even more. New Medicare reimbursements come online for physicians, for Medicare Advantage, and to treat various illnesses.
-
Health Care Disruptors To Watch
Competition within the industry along with new competitors from outside of the industry are all disrupting the status quo. We examine a few of those disruptors and how those could drive change.